Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
BELLICUM PHARMACEUTICALS, INC has filed 611 SEC EDGAR filings since 23 Mar 2006

SEC filing history

Showing 276-300 of 606 matching filings.

Per page
25
Current page
12
4

FORM 4

Filing date
07 Feb 2019
Reporting date
05 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88493

SC 13G/A filing

Filing date
04 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88493

NONE

Filing date
18 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Jan 2019
Reporting date
16 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2018
Reporting date
20 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Dec 2018
Reporting date
20 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2018
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Dec 2018
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36783

FORM 8-K

Filing date
19 Dec 2018
Reporting date
14 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36783

FORM 8-K

Filing date
13 Dec 2018
Reporting date
13 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Nov 2018
Reporting date
09 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36783

8-K

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88493

SC 13G/A filing

Filing date
10 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .